Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Clinical trial NCT04373317 · RECRUITING
Trial details
- NCT number
- NCT04373317
- Sponsor
- VA Office of Research and Development
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-24
- Primary completion
- 2027-10-24
- Enrollment
- 358
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.